Mylan Laboratories Limited
Records under this name other than the patents Mylan Laboratories Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 12 patents it holds.
Back to Mylan Laboratories Limited
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,838,552 | Compositions Comprising Nebivolol Formerly held In force · High confidence | In force | High confidence | |
| US 8,143,435 | One pot process for the preparation of candesartan Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,344,159 | Carvedilol phosphate sesquihydrate Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,026,356 | Process for the large scale production of Stavudine Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,048,904 | Process for the preparation of olmesartan medoxomil Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,258,312 | Process for preparing pure valsartan Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,309,723 | Preparation of Zopiclone and its enantiomerically enriched isomer Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,318,930 | Process for preparing polymorphic forms of (S)-6-chloro-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,329,952 | Process for the preparation of O-desmethylvenlafaxine succinate polymorphic forms Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,350,030 | Process for producing 5-fluoro-1-(2R, 5S)-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine Formerly held In force · From the USPTO record | In force | From the USPTO record |